Insider · CIK 0001445826

Epstein David R

Reports to the SEC for 9 companies · ANTWERP

sec.gov

Transactions

Companies

Filings

CIK

0001445826

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	AGMBAgomAb Therapeutics NVP Purchase	Director	PPurchase	+5,000 sh	$8.90	+$44.5K	15,000
2026-10-06	AGMBAgomAb Therapeutics NVP Purchase	Director	PPurchase	+5,000 sh	$8.70	+$43.5K	10,000
2026-10-05	AGMBAgomAb Therapeutics NVP Purchase	Director	PPurchase	+5,000 sh	$8.57	+$42.9K	5,000
2026-09-01	TEMTempus AI, Inc.S Sale	Director	SSale	−250 sh	$65.55	−$16.4K	30,844
2026-08-03	TEMTempus AI, Inc.S Sale	Director	SSale	−370 sh	$43.40	−$16.1K	31,094
2026-06-01	TEMTempus AI, Inc.S Sale	Director	SSale	−250 sh	$49.40	−$12.4K	31,464
2026-05-21	TEMTempus AI, Inc.A Award	Director	AAward	+5,913 sh	—	—	31,714
2026-02-02	TEMTempus AI, Inc.S Sale	Director	SSale	−370 sh	$59.41	−$22K	26,051
2025-12-01	TEMTempus AI, Inc.S Sale	Director	SSale	−250 sh	$75.55	−$18.9K	26,421
2025-11-03	TEMTempus AI, Inc.S Sale	Director	SSale	−370 sh	$90.00	−$33.3K	26,671
2025-09-02	TEMTempus AI, Inc.S Sale	Director	SSale	−250 sh	$73.64	−$18.4K	27,041
2025-08-01	TEMTempus AI, Inc.S Sale	Director	SSale	−370 sh	$55.16	−$20.4K	27,291
2025-06-02	TEMTempus AI, Inc.S Sale	Director	SSale	−250 sh	$55.20	−$13.8K	27,661
2025-05-20	TEMTempus AI, Inc.A Award	Director	AAward	+1,997 sh	—	—	27,911
2025-05-01	TEMTempus AI, Inc.S Sale	Director	SSale	−370 sh	$53.50	−$19.8K	25,914
2025-03-17	TEMTempus AI, Inc.S Sale	Director	SSale	−990 sh	$46.83	−$46.4K	26,284
2025-03-03	TEMTempus AI, Inc.S Sale	Director	SSale	−250 sh	$57.52	−$14.4K	27,274
2025-02-03	TEMTempus AI, Inc.S Sale	Director	SSale	−370 sh	$53.31	−$19.7K	27,524
2024-12-11	TEMTempus AI, Inc.S Sale	Director	SSale	−620 sh	$41.81	−$25.9K	27,894
2024-06-13	TEMTempus AI, Inc.A Award	Director	AAward	+28.5K sh	—	—	28,514
2023-12-14	Seagen Inc.Performance Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−3,965 sh	—	—	0
2023-12-14	Seagen Inc.D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−16.4K sh	$229.00	−$3.76M	0
2023-12-14	Seagen Inc.Performance Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−6,608 sh	—	—	0
2023-12-14	Seagen Inc.Performance Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−2,644 sh	—	—	0
2023-12-14	Seagen Inc.Restricted Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−39.7K sh	—	—	0
2023-12-14	Seagen Inc.Restricted Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−80.5K sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−224K sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−240K sh	—	—	0
2023-12-14	Seagen Inc.Performance Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−7,930 sh	—	—	0
2023-12-14	Seagen Inc.Performance Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−13.2K sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−2,896 sh	—	—	0
2023-12-14	Seagen Inc.Performance Stock UnitsD Disposition to Issuer	Director, CEO	DDisposition to Issuer	−5,286 sh	—	—	0
2023-11-10	Seagen Inc.S Sale	Director, CEO	SSale	−10.6K sh	$213.01	−$2.26M	136,598
2023-08-15	Seagen Inc.A Award	Director, CEO	AAward	+39.7K sh	—	—	147,218
2022-11-09	Seagen Inc.Non-Qualified Stock Option (Right to Buy)A Award	Director, CEO	AAward	+400K sh	—	—	400,000
2022-11-09	Seagen Inc.Incentive Stock Option (Right to Buy)A Award	Director, CEO	AAward	+2,896 sh	—	—	2,896
2022-11-09	Seagen Inc.A Award	Director, CEO	AAward	+107K sh	—	—	107,389
2022-11-09	Seagen Inc.Non-Qualified Stock Option (Right to Buy)A Award	Director, CEO	AAward	+240K sh	—	—	240,451
2022-07-13	SNTISenti Biosciences Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+125K sh	—	—	125,000
2022-06-30	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,053 sh	—	—	0
2022-06-30	Evelo Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,053 sh	—	—	91,058
2022-06-30	Evelo Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,874 sh	—	—	93,932
2022-06-30	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,874 sh	—	—	0
2022-06-10	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-08	SNTISenti Biosciences Holdings, Inc. · Class B Common StockM Exercise/Conversion	Director	MExercise/Conversion	−113K sh	—	—	0
2022-06-08	SNTISenti Biosciences Holdings, Inc.A Award	Director	AAward	+113K sh	—	—	123,252
2022-05-31	Evelo Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,052 sh	—	—	86,132
2022-05-31	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,873 sh	—	—	2,874
2022-05-31	Evelo Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,873 sh	—	—	89,005
2022-05-31	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,052 sh	—	—	2,053

Recent filings

Accepted (ET)
Oct 9 08:014
Epstein David R0001445826-26-000014
SEC(opens sec.gov)
Oct 7 08:574
Epstein David R0001445826-26-000013
SEC(opens sec.gov)
Sep 34
Epstein David R0001445826-26-000012
SEC(opens sec.gov)
Aug 54
Epstein David R0001445826-26-000010
SEC(opens sec.gov)
Jun 34
Epstein David R0001445826-26-000008
SEC(opens sec.gov)
May 264
Epstein David R0001445826-26-000006
SEC(opens sec.gov)
Feb 44
Epstein David R0001445826-26-000002
SEC(opens sec.gov)
Dec 34
Epstein David R0001445826-25-000006
SEC(opens sec.gov)
Nov 54
Epstein David R0001445826-25-000004
SEC(opens sec.gov)
Sep 44
Epstein David R0001415889-25-023653
SEC(opens sec.gov)
Aug 54
Epstein David R0001415889-25-021029
SEC(opens sec.gov)
Jun 44
Epstein David R0001415889-25-015575
SEC(opens sec.gov)
May 224
Epstein David R0001415889-25-014307
SEC(opens sec.gov)
May 54
Epstein David R0001415889-25-011951
SEC(opens sec.gov)
Mar 194
Epstein David R0001415889-25-008656
SEC(opens sec.gov)
Mar 54
Epstein David R0001415889-25-006936
SEC(opens sec.gov)
Feb 54
Epstein David R0001415889-25-003151
SEC(opens sec.gov)
Dec 134
Epstein David R0001415889-24-029368
SEC(opens sec.gov)
Jun 174
Epstein David R0001415889-24-017306
SEC(opens sec.gov)

Companies

Address

C/O AGOMAB THERAPEUTICS NV POSTHOFLEI 1/6

ANTWERP, 2600